ERYTHROPOIETIN for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 43 adverse event reports in the FDA FAERS database where ERYTHROPOIETIN was used for Off label use.
Most Reported Side Effects for ERYTHROPOIETIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product storage error | 1,286 | 16.2% | 1 | 20 |
| Death | 871 | 10.9% | 854 | 62 |
| Circumstance or information capable of leading to medication error | 592 | 7.4% | 0 | 3 |
| Off label use | 590 | 7.4% | 66 | 130 |
| Haemoglobin decreased | 443 | 5.6% | 18 | 143 |
| Drug ineffective | 370 | 4.7% | 31 | 74 |
| Anaemia | 367 | 4.6% | 36 | 157 |
| Intercepted product administration error | 301 | 3.8% | 0 | 2 |
| Incorrect product storage | 268 | 3.4% | 0 | 9 |
| Fatigue | 266 | 3.3% | 21 | 62 |
| Drug dose omission | 240 | 3.0% | 4 | 20 |
| Hospitalisation | 229 | 2.9% | 24 | 211 |
| Aplasia pure red cell | 204 | 2.6% | 9 | 66 |
| Asthenia | 173 | 2.2% | 28 | 65 |
| Dyspnoea | 173 | 2.2% | 22 | 67 |
Other Indications for ERYTHROPOIETIN
Product used for unknown indication (4,000)
Anaemia (1,269)
Nephrogenic anaemia (750)
Chronic kidney disease (482)
Myelodysplastic syndrome (215)
Haemoglobin decreased (128)
End stage renal disease (73)
Anaemia of chronic disease (57)
Renal failure (36)
Hypertension (32)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)